Continuous Bioprocessing Market Size, Share & Trends Analysis Report
Continuous Bioprocessing Market The global continuous bioprocessing marke t was valued at USD 349.3 million in 2024 and is projected to reach USD 911.4 million by 2030, expanding at a compound annual growth rate (CAGR) of 18.63% from 2025 to 2030. This rapid growth trajectory is primarily fueled by the increasing demand for cost-effective, scalable, and efficient biopharmaceutical manufacturing solutions, especially in the production of monoclonal antibodies, vaccines, and cell & gene therapies. The adoption of process intensification strategies, underpinned by automation, real-time monitoring technologies, and single-use systems, is significantly improving overall productivity while simultaneously reducing operational expenses. Furthermore, global regulatory authorities, including the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), are actively promoting the i...